Krishna Institute of Medical Sciences Quarterly Results

Latest Quarter Net Profit
₹75 Cr
QSept 2026
Quarterly Results

Krishna Institute of Medical Sciences quarterly results. In Sept 2026, Krishna Institute of Medical Sciences (KIMS) reported revenue ₹1,376 Cr and net profit ₹75 Cr — revenue +42.6% YoY. For annual financials, live price and key ratios, visit KIMS share price.

KIMS Quarterly Results — Revenue, Profit & EPS Highlights

Krishna Institute of Medical Sciences latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore Krishna Institute of Medical S share price performance to track price trends across different timeframes.

  • Revenue of ₹1,376 Cr in Sept 2026 (+26.6% vs Mar 2026, +42.6% vs Sept 2025)
  • Net Profit of ₹75 Cr in Sept 2026 (+127.3% vs Mar 2026, +4.2% vs Sept 2025)
  • EBITDA of ₹292 Cr in Sept 2026 (+40.4% vs Mar 2026)
  • Operating Margin of 19.0% in Sept 2026 (+1.0pp vs Mar 2026)
  • Earnings Per Share of ₹1.79 in Sept 2026 (+68.9% vs Mar 2026)

Krishna Institute of Medical Sciences Quarterly Results — Revenue, EBITDA, Net Profit & EPS

KIMS quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 1,376 1,087 1,197 965 812 26.6% 42.6%
Net Profit (₹ Cr) 75 33 37 72 106 - -
EBITDA (₹ Cr) 292 208 241 208 213 - -
EPS (₹) 1.79 1.06 1.04 1.67 2.54 - -
Operating Margin (%) 19.0% 18.0% 19.0% 21.0% 25.0% - -

KIMS Share Price Trend — 1-Year Movement Across Quarterly Results

Krishna Institute of Medical Sciences 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. View Krishna Institute of Medical S yearly highs lows for the annual high/low range and current price position.

Profitability Ratios

Profit Margin 5.5%
EBITDA Margin 21.2%
Operating Margin 19.0%
ROE (Annual) 11.7%

Balance Sheet Highlights

Total Assets ₹7,759 Cr
Total Equity ₹2,559 Cr
Current Assets ₹ Cr
Current Liabilities ₹3,961 Cr

Cash Flow Analysis

Operating Cash Flow ₹511 Cr
Investing Cash Flow ₹-1,452 Cr
Financing Cash Flow ₹940 Cr
Net Cash Flow ₹-1 Cr

Current Market Data

Current Price ₹767.80
Exchange NSE
Last Updated Nov 19, 2026

KIMS vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Krishna Institute of Medical Sciences latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores